Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Feb 27, 2025 10-K Annual report which provides a comprehensive overview of the company for the past year View HTML
0001714899-25-000066.pdf
0001714899-25-000066.rtf
0001714899-25-000066.xls
Feb 27, 2025 8-K Report of unscheduled material events or corporate event View HTML
0001714899-25-000067.pdf
0001714899-25-000067.rtf
0001714899-25-000067.xls
Feb 27, 2025 S-3ASR S-3ASR View HTML
0001628280-25-008647.pdf
0001628280-25-008647.rtf
0001628280-25-008647.xls
Feb 27, 2025 S-8 Securities offered to employees pursuant to employee benefit plans View HTML
0001714899-25-000068.pdf
0001714899-25-000068.rtf
0001714899-25-000068.xls
Feb 13, 2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
0001422848-25-000029.pdf
0001422848-25-000029.rtf
0001422848-25-000029.xls
Feb 12, 2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
0001088875-25-000027.pdf
0001088875-25-000027.rtf
0001088875-25-000027.xls
Jan 13, 2025 8-K Report of unscheduled material events or corporate event View HTML
0001714899-25-000054.pdf
0001714899-25-000054.rtf
0001714899-25-000054.xls
Jan 08, 2025 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-25-000048.pdf
0001714899-25-000048.rtf
0001714899-25-000048.xls
Jan 08, 2025 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-25-000051.pdf
0001714899-25-000051.rtf
0001714899-25-000051.xls
Jan 08, 2025 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-25-000049.pdf
0001714899-25-000049.rtf
0001714899-25-000049.xls
Pagination
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • …
  • Next page ›
  • Last page »
Displaying 21 - 30 of 708 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use